HAWAII MINORITY BASED CCOP

夏威夷少数民族 CCOP

• 批准号: 2712695
• 负责人: BRIAN F ISSELL
• 金额: $ 34.54万
• 依托单位: UNIVERSITY OF HAWAII AT MANOA
• 依托单位国家: 美国
• 财政年份: 1994
• 资助国家: 美国
• 起止时间: 1994-08-01 至 2000-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2712695
• 关键词: Asians; Hawaii; behavioral /social science research tag; cancer prevention; cancer rehabilitation /care; cancer risk; clinical research; clinical trials; community health services; cooperative study; health care service availability; health services research tag; human subject; human therapy evaluation; neoplasm /cancer therapy; oncology; primary care physician

The object of the Hawaii Minority-Based Community Clinical Oncology Program (MB-CCOP) is to build on its past several years' success in providing NCI clinical trails to Hawaii cancer patients and high risk individuals in order to reduce cancer incidence, morbidity, and mortality by: 1: providing support to expand clinical research in the state of Hawaii, a multiethnic population with a majority of non-Caucasian cancer patients; 2. Bring the advantages of state-of-the-art treatment and cancer prevention and control research to minority individuals in their own communities; 3. Increasing the involvement of primary health care providers and other specialists in cancer treatment, prevention and control studies; 4. Facilitating wider participation among underserved populations in NCI-approved research; 5. Strengthening the operational base that currently exists to extend cancer prevention and control research in this population. The Cancer Research Center of Hawaii will serve as the administrative headquarters for the MB-COOP to direct recruitment, accrual, and data management for NCI-approved cancer treatment and control clinical trials. The Southwest Oncology Group, M.D.Anderson, University of Rochester Cancer Center, Gynecologic Oncology Group, and the Pediatric Oncology Group are the Hawaii MB-CCOP research bases. The participating physicians include all oncologists on the island of Oahu, as well as professionals from other medical and nonmedical specialties. All major Oahu hospitals will serve as component institutions. The MB-CCOP will allow the people of Hawaii, about 75 percent of whom are Asian and Pacific Islanders, to benefit from access to state-of-the-art cancer treatment and control interventions.

夏威夷少数民族社区临床肿瘤学的目标 计划（MB-CCOP）是建立在其过去几年的成功， 为夏威夷癌症患者和高风险患者提供NCI临床试验， 个人，以减少癌症发病率，发病率， 死亡率：1：提供支持，以扩大在 夏威夷州，多民族人口， 非高加索癌症患者; 2.带来的好处 最先进的治疗和癌症预防和控制研究 在自己的社区中的少数群体; 3。增加 初级保健提供者和其他专家的参与 癌症治疗、预防和控制研究; 4.促进 获得服务不足的人口更广泛地参与国家信息理事会批准的 研究; 5.加强现有的业务基础 在这一人群中推广癌症预防和控制研究。 夏威夷癌症研究中心将作为行政管理机构， MB-COOP总部负责指导招聘、应计和数据 管理NCI批准的癌症治疗和控制临床 审判 西南肿瘤组，医学博士安德森，大学 罗切斯特癌症中心，妇科肿瘤组，和 儿科肿瘤组是夏威夷MB-CCOP研究基地。 的 参与的医生包括岛上的所有肿瘤学家， 以及其他医疗和非医疗专业人员 特产 所有主要的奥匈帝国医院将作为组成部分， 机构职能体系 MB-CCOP将允许夏威夷人民，大约75 其中70%是亚洲和太平洋岛民， 获得最先进的癌症治疗和控制 干预措施。